Pancreatic Cancer Clinical Trials

Showing 881-900 of 1,185 trials

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

NCT00790569

RATIONALE: Varenicline, the nicotine patch, and nicotine gum help people stop smoking. It is not yet known whether varenicline is more effective than the nicotine patch given together with nicotine gum in helping smokers quit smoking. PURPOSE: This randomized clinical trial is studying varenicline to see how well it works compared with the nicotine patch given together with nicotine gum in helping smokers in a methadone treatment program stop smoking.

Bladder CancerCervical CancerEsophageal Cancer+8 more

Butler Hospital315 participantsStarted Sep 2008

Providence, Rhode Island, United States

COMPLETEDPhase 2

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

NCT02004262

Test the safety, immune response and efficacy of GVAX pancreas vaccine (with cyclophosphamide) and CRS-207 compared to chemotherapy or CRS-207 alone in adults with previously treated metastatic pancreatic adenocarcinoma

2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer

Aduro Biotech, Inc.303 participantsStarted Feb 2014

Scottsdale, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +18 more locations

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Related Searches

On-site Cytopathology EUS-FNA

Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Molecularly Tailored Therapy for Pancreas Cancer

Shark Mouth Modified Pancreaticojejunostomy

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer

Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures

Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Chemoradiation in Locally Advanced Pancreatic Cancer

Registry for Pancreatic Cancer

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab